Control of parturition in hyperprolific sows by using altrenogest and double administrations of PGF2α

Injectable and In Situ Phospholipid-Based Phase Separation Gel for Sustained Delivery of Altrenogest

Altrenogest is a key regulatory hormone for intensive and batch management of reserve sows in breeding farms. As a synthetic hormone, altrenogest could make ovaries stay at the initial stage of follicles and inhibit estrus and ovulation in animals. However, the currently used oral altrenogest solution needs to be administered continuously every day for more than two weeks in clinical practice. In this study we developed a phospholipid-based injectable gel carrying altrenogest to decrease the number of administrations, sustain release of the drug, and enhance therapeutic efficacy for clinical use. The altrenogest gel had a viscosity of 100 cP before phase transition and over 1,000,000 cP after phase transition. In vitro, altrenogest can be continuously released from gel for over two weeks. The pharmacokinetic results showed that the AUC (0-∞) of the altrenogest gel was almost double that of the altrenogest solution. The MRT (0-∞) was 40.92 ± 7.21 h and the t1/2 of the altrenogest gel was 80.03 ± 20.79 h. The altrenogest gel demonstrated excellent fluidity, ease of injectability, high drug-loading capacity, and appropriate sustained-release characteristics both in vitro and in vivo, making it a potential drug delivery system for swine production.

Factors Associated with Farrowing Duration in Hyperprolific Sows in a Free Farrowing System under Tropical Conditions

The ongoing selection for increased litter size has had significant impacts on sow husbandry practice. The present study investigated factors associated with farrowing duration and the proportion of sows that had prolonged farrowing in modern hyperprolific sows kept in a free farrowing system in a tropical environment. Farrowing data from 2493 Landrace x Yorkshire cross-bred sows in a commercial swine herd in Thailand were included in the study. The time of farrowing, parity number, litter size, and the birth status of each piglet were recorded. Farrowing duration was analysed using multiple analyses of variance. Total number of piglets born per litter (TB), parity, and time onset of farrowing were included in the statistical models. On average, TB, piglets born alive, and farrowing duration were 13.7, 12.1, and 221.0 min, respectively. Of these sows, 26.4% had TB ≥ 16 and 21.7% had a prolonged farrowing duration (≥300 min). Farrowing duration was positively correlated with TB (r = 0.141, p < 0.001), percentage of stillborn (SB) piglets per litter (r = 0.259, p < 0.001), percentage of mummified foetuses (MF) per litter (r = 0.049, p = 0.015), piglet birth weight (r = 0.068, p < 0.001), and litter birth weight (r = 0.041, p = 0.043). The proportion of SB per litter was higher and piglet birth weight lower in litters that had ≥16 TB than those with 8−12 TB (p < 0.05). The farrowing duration of sows with parity numbers 5−7 (247.7 ± 5.1 min) and 8−10 (237.1 ± 5.1 min) was longer than that of sows with parity numbers 1 (188.3 ± 5.2 min) and 2−4 (214.3 ± 3.9 min) (p < 0.05). Sows that had started farrowing during working hours had longer farrowing durations (229.3 ± 3.6 min) than those that had started farrowing during non-working hours (217.6 ± 3.4 min, p = 0.017). In multiparous sows, the duration of farrowing was positively correlated with the maximum temperature (r = 0.056, p = 0.012) and the maximum temperature−humidity index (r = 0.059, p = 0.008) in the 7 days before farrowing. The present data confirm that TB, sow parity, and time of onset of farrowing are significant risk factors for a prolonged farrowing.

Effect of a combination of altrenogest and double PGF2α administrations on farrowing variation, piglet performance and colostrum IgG

The variation of gestation length in sows leads to difficulties performing farrowing supervision. The present study was performed to investigate whether oral administration of altrenogest until 112 days of gestation and double administration of PGF2α at 113 days of gestation can synchronise the onset of parturition in sows and minimise deleterious effects on the incidence of stillbirths and colostrum quality. Additionally, the effects of synchronised farrowing on colostrum yield and piglet birth weight, colostrum intake and survival rate of piglets until seven days of postnatal life were also investigated. In total, 193 Landrace x Yorkshire crossbred sows were randomly allocated according to parity number into two groups, i.e. control (n = 95) and treatment (n = 98). The control sows were allowed to farrow naturally. The treatment sows were orally administered 20 mg per day of altrenogest for four days from 109 to 112 days of gestation and were administered PGF2α twice on day 113 of gestation. Individual body weight at birth and 24 h after birth of piglets in all litters were determined in both control (n = 1609) and treatment (n = 1707) groups. Colostrum consumption of all piglets, colostrum yield, colostrum IgG and serum progesterone of sows were determined. On average, the total number of piglets born per litter were 17.0 ± 3.1. The proportion of sows farrowed before 114 days of gestation was higher in the control than the treatment group (8.4% and 2.0%, respectively, P = 0.05) and 92.8% of sows in the treatment group farrowed on day 114 of gestation. The percentage of stillborn piglets per litter did not differ significantly between control and treatment groups (4.5% and 4.6%, respectively). Colostrum yield of sows did not differ between control and treatment groups (5.52 ± 0.13 and 5.28 ± 0.12 kg, respectively, P = 0.174). However, colostrum intake of piglets was lower in the treatment than the control group (354.7 ± 6.6 and 381.2 ± 7.0 g, respectively, P = 0.012). Colostrum IgG was higher in the control than the treatment group (41.2 ± 1.1 and 37.3 mg per ml, P = 0.013). In conclusion, altrenogest treatment from 109 to 112 days and double administrations of PGF2α on day 113 of gestation can control gestation length in sows. No deleterious effects of this protocol on the incidence of stillbirths and sow colostrum yield were detected. However, piglet colostrum intake and colostrum IgG were compromised. Thus, care of newborn piglets in the treatment group should be considered.

Effects of farrowing induction using cloprostenol on sow farrowing characteristics

Background and Aim: Previous findings regarding the effects of farrowing induction on the farrowing characteristics of sows are controversial. This study aimed to investigate the effects of farrowing induction on the following characteristics: (1) Proportion of sows that farrowed during working hours, (2) stillbirth rate, (3) number of stillbirths per farrow, (4) dystocia rate per farrow, (5) dystocia rate (the proportion of farrowings that had at least one dystocia event), (6) number of dystocia events per farrow, (6) farrowing duration, (7) birth interval, and (8) birth weight. Materials and Methods: Thirty-eight Landrace x Yorkshire sows were randomly allocated into two groups; the control group and the treatment group. In the control group (n = 18), sows farrowed spontaneously. In the treatment group (n = 20), farrowing was induced approximately 2 days earlier than the herd's average length of gestation (7:00 am on day 114) by injecting cloprostenol into the perivulval region. All sows were supervised throughout their farrowing. We recorded the interval between induction and farrowing; total number of births; number of live, stillborn, and mummified piglet births; number of dystocia events; birth interval; farrowing duration; and birth weight. A generalized linear mixed model, a linear mixed-effects model, the Chi-squared test, and Student's t-test were used to compare outcomes between the two groups. Results: Farrowing induction did not influence the percentage of sows that farrowed during working hours (7 am–5 pm), stillbirth rate, birth weight, and number of dystocia events per farrow. Farrowing induction led to an increase in birth interval, dystocia rate, dystocia per farrow (p < 0.05) and in addition to the percentage of sows that farrowed on the day following induction (60% vs. 27.8%; p < 0.05). Conclusion: Farrowing induction using a single dose of cloprostenol 2 days before the expected farrowing date can be performed with care to concentrate farrowing into a short interval. This can enhance the optimization of cross-fostering and the practice of an all-in-all-out strategy in the swine breeding industry.